Risk scores are statistical indicators based on prescribing patterns compared to specialty peers. They are NOT allegations of fraud, misconduct, or improper care. Many legitimate medical reasons can explain outlier prescribing.
Read our methodology →Risk Flags
Risk indicators are statistical patterns, not allegations. Learn more
20,791
Total Claims
$1.5M
Drug Cost
1,016
Beneficiaries
$1,438
Cost/Patient
Risk Score Breakdown 24/100
Score components are additive. Read full methodology
Peer Comparison vs. 106,889 Family Practice providers
-24%
Opioid rate vs peers
2.0% vs 2.6% avg
+35%
Cost per patient vs peers
$1,438 vs $1,068 avg
+92%
Brand preference vs peers
17.3% vs 9.0% avg
⚠️ Opioid + Benzodiazepine Co-Prescriber
This provider prescribes both opioids and benzodiazepines. The FDA has issued a Black Box Warning about the life-threatening risks of concurrent use.
Opioid Prescribing
2.0%
Opioid Rate
406
Opioid Claims
$14K
Opioid Cost
10.6%
Long-Acting Rate
Brand vs Generic
Brand: 3,581 claims · $1.1M
Generic: 17,098 claims · $403K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 830 | $304K |
| Insulin Glargine,hum.Rec.Anlog | 146 | $56K |
| Mirabegron | 210 | $52K |
| Dulaglutide | 68 | $45K |
| Rivaroxaban | 110 | $39K |
| Fluticasone/Umeclidin/Vilanter | 53 | $39K |
| Lipase/Protease/Amylase | 58 | $35K |
| Tirzepatide | 22 | $29K |
| Pimavanserin Tartrate | 11 | $24K |
| Tiotropium Bromide | 36 | $23K |
| Empagliflozin | 65 | $23K |
| Brexpiprazole | 28 | $20K |
| Rifaximin | 12 | $20K |
| Semaglutide | 15 | $19K |
| Dapagliflozin Propanediol | 52 | $18K |
Prescribing Profile
Patient Profile
78
Avg Age
63%
Female
1.79
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations.Methodology · About